Over the last two decades there has been a broad paradigm shift in our understanding of gastric cancer (GC) and its premalignant states from gross histological models to increasingly precise molecular descriptions. In this review we reflect upon the historic approaches to describing premalignant lesions and GC, highlight the current molecular landscape and how this could inform future risk assessment prevention strategies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755108 | PMC |
http://dx.doi.org/10.4251/wjgo.v11.i9.665 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!